NO20021234L - Use of thienopyrimidines - Google Patents

Use of thienopyrimidines

Info

Publication number
NO20021234L
NO20021234L NO20021234A NO20021234A NO20021234L NO 20021234 L NO20021234 L NO 20021234L NO 20021234 A NO20021234 A NO 20021234A NO 20021234 A NO20021234 A NO 20021234A NO 20021234 L NO20021234 L NO 20021234L
Authority
NO
Norway
Prior art keywords
thienopyrimidines
Prior art date
Application number
NO20021234A
Other languages
Norwegian (no)
Other versions
NO20021234D0 (en
Inventor
Rochus Jonas
Volker Eiermann
Sabine Bernotat-Danielowski
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20021234D0 publication Critical patent/NO20021234D0/en
Publication of NO20021234L publication Critical patent/NO20021234L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO20021234A 1999-09-14 2002-03-13 Use of thienopyrimidines NO20021234L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19943815A DE19943815A1 (en) 1999-09-14 1999-09-14 Use of thienopyrimidines
PCT/EP2000/008258 WO2001019369A1 (en) 1999-09-14 2000-08-24 Use of thienopyrimidines

Publications (2)

Publication Number Publication Date
NO20021234D0 NO20021234D0 (en) 2002-03-13
NO20021234L true NO20021234L (en) 2002-03-13

Family

ID=7921854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021234A NO20021234L (en) 1999-09-14 2002-03-13 Use of thienopyrimidines

Country Status (18)

Country Link
EP (1) EP1212062A1 (en)
JP (1) JP2003509370A (en)
KR (1) KR20020026011A (en)
CN (1) CN1377271A (en)
AR (1) AR025645A1 (en)
AU (1) AU6703200A (en)
BR (1) BR0013957A (en)
CA (1) CA2387123A1 (en)
CZ (1) CZ2002818A3 (en)
DE (1) DE19943815A1 (en)
HU (1) HUP0202614A3 (en)
MX (1) MXPA02002746A (en)
NO (1) NO20021234L (en)
PL (1) PL353343A1 (en)
RU (1) RU2002107441A (en)
SK (1) SK3322002A3 (en)
WO (1) WO2001019369A1 (en)
ZA (1) ZA200202868B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK8032003A3 (en) * 2000-12-19 2003-11-04 Merck Patent Gmbh Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
DE10135815A1 (en) * 2001-07-23 2003-02-06 Bayer Ag Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
JP3370340B2 (en) * 1996-04-12 2003-01-27 ワーナー―ランバート・コンパニー Irreversible inhibitors of tyrosine kinase
DE19644228A1 (en) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidines
DE19819023A1 (en) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidines
US5948911A (en) * 1998-11-20 1999-09-07 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
AU3453900A (en) * 1999-03-30 2000-10-23 Nippon Soda Co., Ltd. Thienopyrimidine compounds and salts thereof and process for the preparation of the same

Also Published As

Publication number Publication date
HUP0202614A2 (en) 2002-12-28
CN1377271A (en) 2002-10-30
JP2003509370A (en) 2003-03-11
ZA200202868B (en) 2003-11-26
CZ2002818A3 (en) 2002-06-12
DE19943815A1 (en) 2001-03-15
AR025645A1 (en) 2002-12-04
RU2002107441A (en) 2003-11-20
AU6703200A (en) 2001-04-17
WO2001019369A1 (en) 2001-03-22
HUP0202614A3 (en) 2004-11-29
CA2387123A1 (en) 2001-03-22
KR20020026011A (en) 2002-04-04
SK3322002A3 (en) 2002-07-02
BR0013957A (en) 2002-05-21
NO20021234D0 (en) 2002-03-13
EP1212062A1 (en) 2002-06-12
PL353343A1 (en) 2003-11-17
MXPA02002746A (en) 2002-10-23

Similar Documents

Publication Publication Date Title
AR028567A1 (en) NEW DERIVATIVES OF FENIL-PROPARGILETER
ID30233A (en) ANTIBIOTICS OF TETOLIDA
NO20022979D0 (en) Use of organic compounds
AR028596A1 (en) NEW DERIVATIVES OF PHENYLGLYCIN
ID30187A (en) DONGKRAK KIND OF PANTAGRAF
PL361277A1 (en) Use of thienopyrimidines
NO20041968L (en) Use of cystationin
NO20016151D0 (en) Preparation of substituted piperidin-4-ones
PT1322592E (en) SUBSTITUTED DERIVATIVES OF 1-AMINOBUTAN-3-OL
ID28032A (en) TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2
PT1178984E (en) DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME
NO20014845D0 (en) Use of arylalkanoylpyridazines
PT1175417E (en) SUBSTITUTED COMPOUNDS OF BENZOLACTAMAS
NO20021234L (en) Use of thienopyrimidines
PT1232141E (en) ETERIES OF O-DESMETIL-VENLAFAXIN
NO20016030L (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homothylosin
PT1020132E (en) ABA OF PUTTING AWAY
NO20005856D0 (en) Use of 1,1-dioxo-perhydro-1,2,4-thiadiazines
SE9902239D0 (en) Kornisch consisting of several parts
NO20022671D0 (en) Process for the preparation of thienopyrimidines
EE200200053A (en) Process of preparation of isoretinoin
SE9903009D0 (en) Use of new responsive elements
SE9904269D0 (en) Use of new responsive elements
FI4225U1 (en) Special part of technical equipment
SE9901114D0 (en) Reduction of Nox

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application